These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34320918)

  • 1. Changes in kynurenine pathway metabolites after acute psychosocial stress in healthy males: a single-arm pilot study.
    La Torre D; Dalile B; de Loor H; Van Oudenhove L; Verbeke K
    Stress; 2021 Nov; 24(6):920-930. PubMed ID: 34320918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
    Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
    Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise and the Kynurenine pathway: Current state of knowledge and results from a randomized cross-over study comparing acute effects of endurance and resistance training.
    Joisten N; Kummerhoff F; Koliamitra C; Schenk A; Walzik D; Hardt L; Knoop A; Thevis M; Kiesl D; Metcalfe AJ; Bloch W; Zimmer P
    Exerc Immunol Rev; 2020; 26():24-42. PubMed ID: 32139353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy.
    Wang Y; Fang X; Wang G; Tang W; Liu S; Yang Y; Chen J; Ling Y; Zhou C; Zhang X; Zhang C; Su KP
    Brain Behav Immun; 2023 Oct; 113():1-11. PubMed ID: 37353059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune-kynurenine pathway in social anxiety disorder.
    Butler MI; Long-Smith C; Moloney GM; Morkl S; O'Mahony SM; Cryan JF; Clarke G; Dinan TG
    Brain Behav Immun; 2022 Jan; 99():317-326. PubMed ID: 34758380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in plasma kynurenine pathway metabolites in children and adolescents with bipolar disorder and unaffected offspring of bipolar parents: A preliminary study.
    Benevenuto D; Saxena K; Fries GR; Valvassori SS; Kahlon R; Saxena J; Kurian S; Zeni CP; Kazimi IF; Scaini G; Soares JC; Quevedo J
    Bipolar Disord; 2021 Nov; 23(7):689-696. PubMed ID: 33098737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine pathway changes in late-life depression.
    Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
    J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls.
    Zhang Z; Zhang M; Luo Y; Ni X; Lu H; Wen Y; Fan N
    Hum Psychopharmacol; 2020 Jul; 35(4):e2738. PubMed ID: 32352599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy.
    Żarnowska I; Wróbel-Dudzińska D; Tulidowicz-Bielak M; Kocki T; Mitosek-Szewczyk K; Gasior M; Turski WA
    Seizure; 2019 Jul; 69():265-272. PubMed ID: 31129366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE.
    Anderson EW; Jin Y; Shih A; Arazi A; Goodwin S; Roeser J; Furie RA; Aranow C; Volpe B; Diamond B; Mackay M
    Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36384965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus.
    Eryavuz Onmaz D; Tezcan D; Yilmaz S; Onmaz M; Unlu A
    Amino Acids; 2023 Dec; 55(12):1937-1947. PubMed ID: 37925676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of immune activation on the kynurenine pathway and depression symptoms - A systematic review and meta-analysis.
    Hunt C; Macedo E Cordeiro T; Suchting R; de Dios C; Cuellar Leal VA; Soares JC; Dantzer R; Teixeira AL; Selvaraj S
    Neurosci Biobehav Rev; 2020 Nov; 118():514-523. PubMed ID: 32853625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress.
    Kucukkarapinar M; Yay-Pence A; Yildiz Y; Buyukkoruk M; Yaz-Aydin G; Deveci-Bulut TS; Gulbahar O; Senol E; Candansayar S
    J Neural Transm (Vienna); 2022 Aug; 129(8):1077-1089. PubMed ID: 35796878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis.
    Ou W; Chen Y; Ju Y; Ma M; Qin Y; Bi Y; Liao M; Liu B; Liu J; Zhang Y; Li L
    J Affect Disord; 2023 Oct; 339():624-632. PubMed ID: 37467793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder.
    Sakurai M; Yamamoto Y; Kanayama N; Hasegawa M; Mouri A; Takemura M; Matsunami H; Miyauchi T; Tokura T; Kimura H; Ito M; Umemura E; Boku AS; Nagashima W; Tonoike T; Kurita K; Ozaki N; Nabeshima T; Saito K
    Sci Rep; 2020 Feb; 10(1):1961. PubMed ID: 32029791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine pathway in Coronavirus disease (COVID-19): Potential role in prognosis.
    Cihan M; Doğan Ö; Ceran Serdar C; Altunçekiç Yıldırım A; Kurt C; Serdar MA
    J Clin Lab Anal; 2022 Mar; 36(3):e24257. PubMed ID: 35092710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
    Ryan KM; Allers KA; McLoughlin DM; Harkin A
    Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.